14 research outputs found
Dramatic and concerted conformational changes enable rhodocetin to block Ī±2Ī²1 integrin selectively.
The collagen binding integrin Ī±2Ī²1 plays a crucial role in hemostasis, fibrosis, and cancer progression amongst others. It is specifically inhibited by rhodocetin (RC), a C-type lectin-related protein (CLRP) found in Malayan pit viper (Calloselasma rhodostoma) venom. The structure of RC alone reveals a heterotetramer arranged as an Ī±Ī² and Ī³Ī“ subunit in a cruciform shape. RC specifically binds to the collagen binding A-domain of the integrin Ī±2 subunit, thereby blocking collagen-induced platelet aggregation. However, until now, the molecular basis for this interaction has remained unclear. Here, we present the molecular structure of the RCĪ³Ī“-Ī±2A complex solved to 3.0 Ć
resolution. Our findings show that RC undergoes a dramatic structural reorganization upon binding to Ī±2Ī²1 integrin. Besides the release of the nonbinding RCĪ±Ī² tandem, the RCĪ³ subunit interacts with loop 2 of the Ī±2A domain as result of a dramatic conformational change. The RCĪ“ subunit contacts the integrin Ī±2A domain in the "closed" conformation through its helix C. Combined with epitope-mapped antibodies, conformationally locked Ī±2A domain mutants, point mutations within the Ī±2A loop 2, and chemical modifications of the purified toxin protein, this molecular structure of RCĪ³Ī“-Ī±2A complex explains the inhibitory mechanism and specificity of RC for Ī±2Ī²1 integrin
Correction: Dramatic and concerted conformational changes enable rhodocetin to block Ī±2Ī²1 integrin selectively.
[This corrects the article DOI: 10.1371/journal.pbio.2001492.]
Data and refinement statistics of the RCĪ³Ī“-Ī±2A crystal structure.
<p>Data and refinement statistics of the RCĪ³Ī“-Ī±2A crystal structure.</p
Molecular mechanism of the RCĪ³Ī“-Ī±2A interaction.
<p>As RCĪ±Ī²Ī³Ī“ binds to Ī±2A in its āclosedā conformation, it induces the conformational change of Ī±2A from its āopenā to āclosedā conformation and thus shifts the conformational equilibrium (1). This interaction is mediated via the conformationally robust RCĪ“ interaction site within helix C, which is only present in the āclosedā conformation of Ī±2A. Subsequently, the index finger loop of RCĪ³ changes its conformation, which is accompanied by a global movement of both rhodocetin (RC) core domains towards each other and by a release of the RCĪ±Ī² subunit (2). As the RCĪ±Ī² subunit diffuses away, this step is likely irreversible in nature. The global shape change of RCĪ³Ī“ forms a new bay region that embraces Ī±2A and locally leads to the repositioning of RCĪ³ key residues, which forms another binding-competent interacting site in RCĪ³ for the Ī±2A loop 2 (3).</p
An overview of the RCĪ³ and RCĪ“ binding residues, depicting the local conformational changes that occur upon Ī±2A binding.
<p>(<b>A</b>) A comparison of the RCĪ³ subunit binding site (L66/R109/W110) between the RCĪ±Ī²Ī³Ī“ (purple) and RCĪ³Ī“-Ī±2A complex (blue) structures. Due to the global movements within the index finger swapping domain that accompany the formation of the RCĪ³Ī“-Ī±2A complex, a local repositioning of the key Ī±2A interacting residues within RCĪ³ takes place such that they adopt an orientation that is compatible for Ī±2A binding. (<b>B</b>) A comparison between the 2 RCĪ“ subunit binding sites (K59/Y60/K101 and R92/Y94/K114) between the RCĪ±Ī²Ī³Ī“ (yellow) and RCĪ³Ī“-Ī±2A complex (orange) structures. In contrast to RCĪ³, all the RCĪ“ residues involved in Ī±2A binding would be in an Ī±2A-competent orientation in both the RCĪ±Ī²Ī³Ī“ (yellow) and RCĪ³Ī“-Ī±2A complex (orange) structures, with the exception of R92, which forms an internal salt bridge with D74Ī³ in the RCĪ±Ī²Ī³Ī“ tetramer but interacts with D219 of Ī±2A in the RCĪ³Ī“-Ī±2A complex.</p
Loop 2 of the Ī±2A domain is the interaction site for the RCĪ³ subunit.
<p>(<b>A</b>) Loop 2 of Ī±2A is an additional binding site for rhodocetin (RC). It contains the epitope for the monoclonal antibody (mAb) JA202, which inhibits binding of RC to immobilized Ī±2A. Bound RC was quantified by ELISA, and values were normalized to noninhibited controls. One set of inhibition curves out of 3 independent experiments with each measurement made in triplicate and the means Ā± SD for each data point are shown. (<b>B</b>) The Ī±2A loop 2 sequence was replaced with the homologous sequence VGRGGRQ of integrin Ī±1 (Ī±2A L2<sup>Ī±1</sup> mutant). The binding-irrelevant antibody JA218 was immobilized to capture wild-type (wt) Ī±2A and Ī±2A L2<sup>Ī±1</sup>. They were titrated with RC, and bound RC was quantified as in (<b>A</b>). One set of titration curves out of 4 independent experiments, each done in triplicates, is shown with the means Ā± SD indicated. The Ī±2A L2<sup>Ī±1</sup> mutant (light gray ā ) significantly reduced affinity for RC compared to the wt (ā) (<i>p</i> = 0.0013, two-tailed <i>t</i> test) (<b>C</b>) Stereo view of the Ī±2A loop 2 sequence in contact with the RCĪ³ contact site. The Sigma-A weighted 2Fo-Fc map is shown at 1.5Ļ contour level. The 2 glycine residues, G217 and G218, form the bottom of a shallow dimple, which is flanked on either side by the side chains of Y216 and D219, in addition to residue N154 of loop 1 (not shown). The indole side chain of W110Ī³ stacks directly above this dimple and interacts with the main chain of the 2 glycine residues. (<b>D</b>) Point mutation analysis of the Ī±2A loop 2 sequence S<sup>214</sup>QYGGD<sup>219</sup>. The binding activity of these mutants for RC was tested as in (<b>B</b>). Binding signals taken from at least 7 independent titration curves for each mutant were normalized to the saturation signal of wild type Ī±2A. Means Ā± SEM are shown for the mutants (ā of different colors) in comparison to wt (ā) and the Ī±2A L2<sup>Ī±1</sup> mutant (light gray ā ). This analysis showed that the 2 glycines at position 217 and 218 were key to the RCĪ³Ī“-Ī±2A interaction, as only mutations abrogated Ī±2A binding. (<b>E</b>) The K<sub>d</sub> values of the loop 2 point mutations for binding to RC as derived from (<b>D</b>). At least 7 titration curves were evaluated for each mutant. The K<sub>d</sub> values were pairwise compared to the K<sub>d</sub> value of the wild type Ī±2A domain in a two-tailed Student <i>t</i> test. Significant difference (<i>p</i> < 0.02) is asterisked (*). (<b>F</b>) Modification of tryptophan residues of RCĪ³Ī“ with 2-nitrophenyl sulfenylchloride (NPS-Cl) showed that W110Ī³ is required for Ī±2A domain binding. The wells of a microtiter plate were coated with 10 Ī¼g/ml Ī±2A domain and titrated with RCĪ±Ī²Ī³Ī“ (ā), with nonmodified RCĪ³Ī“ (green ā²) and with RCĪ³Ī“ with chemically modified W110Ī³ (W-NPS, red ā¼) One representative out 3 independent titration experiments done in duplicate is shown with the means Ā± SD indicated. The data of plots (<b>A</b>), (<b>B</b>), (<b>D</b>), (<b>E</b>), and (<b>F</b>) are summarized in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2001492#pbio.2001492.s006" target="_blank">S1 Data</a>.</p
The monoclonal antibody IIIG5 recognizes its epitope within the RCĪ³ subunit in the RCĪ³Ī“-Ī±2A complex but not in the tetrameric RCĪ±Ī²Ī³Ī“.
<p>(<b>A</b>) The monoclonal antibody IIIG5 recognized an epitope of the RCĪ³ subunit, which is fully accessible in the RCĪ³Ī“ subunit (ā), partially accessible in the RCĪ³Ī“-Ī±2A complex (light gray ā²), and completely covered in the RCĪ±Ī²Ī³Ī“ tetramer (dark gray ā ). IIIG5 was immobilized on microtiter plates and titrated with RCĪ±Ī²Ī³Ī“, RCĪ³Ī“-Ī±2A complex, or RCĪ³Ī“ subunit. Bound rhodocetin (RC) components were fixed and detected using rabbit RC antiserum with ELISA at 405 nm. The data presented here are taken from 3 independent experiments with each measurement done in duplicate. Means Ā± SD are shown. The data are summarized in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2001492#pbio.2001492.s006" target="_blank">S1 Data</a>. (<b>B</b>) Molecular structure of the C-type lectin-related protein (CLRP)-fold typical of all 4 RC chains. Both the Ī³ and Ī“ subunits of RC are very similar (CĪ±-RMSD 0.8Ć
) and feature a core structure with 2 Ī±-helices (H1 and H2) flanked by 2 antiparallel Ī²-sheets (S1āS2āS6 and S3āS4āS5). The amino acid residues V94āR109 of the IIIG5 epitope of RCĪ³ are highlighted.</p
PCR primers for cloning the Ī±2A loop2 mutants.
<p>PCR primers for cloning the Ī±2A loop2 mutants.</p
Isolation of the rhodocetin Ī³Ī“-Ī±2A complex on Ni Sepharose column.
<p><b>(A)</b> Elution profile of the Ni Sepharose affinity chromatography column. The RCĪ³Ī“-Ī±2A complex was formed on a Ni Sepharose column by subsequently loading the oligo His-tagged Ī±2A domain and RCĪ±Ī²Ī³Ī“. RCĪ±Ī² and the RCĪ³Ī“-Ī±2A complex were eluted with EGTA and an imidazole gradient, respectively. (<b>B</b>) SDS-PAGE of eluate fractions (lanes āEGTA eluateā and āimidazole eluateā), in comparison to isolated control proteins (lanes āĪ±2A domainā and ārhodocetin Ī³Ī“ā), under nonreducing and reducing conditions and stained with silver. Note that the trypsin-trimmed RCĪ³Ī“-Ī±2A complex showed a slightly reduced size of the Ī±2A domain due to the proteolytic removal of the His<sub>6</sub>-tag. The physical contact of co-eluted rhodocetin (RC) Ī³Ī“ and Ī±2A domain was analytically proven by cross-linkage with 0.5 mM BS<sup>3</sup> (lane āCL-imidazole eluateā).</p
A comparison of the RCĪ³Ī“-Ī±2A and EMS16Ī±Ī²-Ī±2A binding interfaces.
<p>(<b>A, B</b>) The C-type lectin-related protein (CLRP) folds of both homologous subunits of RCĪ³Ī“ (<b>A</b>) and EMS16Ī±Ī² (<b>B</b>) are highly homologous with many of the residues involved in the Ī±2A binding conserved between the 2 proteins. These residues have been mapped onto the CLRP fold and colorcoded for rhodocetin (RC) (blue and orange for the Ī³ and Ī“ subunits, respectively, in [<b>A</b>]) and for EMS16 (light blue and magenta for the Ī± and Ī² subunits, respectively, in [<b>B</b>]). The partnering residues of the Ī±2A domain contacted by RC and EMS16 are color coded in white and yellow, respectively. The same colorcoding scheme is used throughout the figure. (<b>C, D</b>) A superposition of the key residues from RCĪ³/EMS16Ī± at the loop 2 binding site (<b>C</b>) and of RCĪ“/EMS16Ī² at the helix C binding site (<b>D</b>), respectively, on Ī±2A. The contact sites are largely conserved between RCĪ³Ī“/EMS16Ī±Ī² and Ī±2A, although there are a couple of notable differences. For example, L66 of RCĪ³ contacts Y216 of Ī±2A in addition to the N154 of loop 1 observed for the corresponding I66 of EMS16Ī±. In addition, K59 of RCĪ“ forms a salt bridge to D292 of Ī±2A, whereas, in EMSĪ², the corresponding K59 points towards helix C.</p